An 88-year-old man died of streptococcal toxic shock syndrome due to a group G streptococcus infection that was possibly caused by an intramuscular injection given 30 hours earlier in his right deltoid muscle. The causative pathogen was later identified to be Streptococcus dysgalactiae subsp. equisimilis (stG485). Although providing intramuscular injections is an essential skill of health care workers that is performed daily worldwide, it may constitute a port of entry for pathogens via skin breaches that can cause life-threatening infections. All invasive procedures should be carefully performed, especially when immunologically compromised patients are involved.
Introduction
Intramuscular (IM) injection is a routine technique for health care workers worldwide. However, its potential complications are not always taken into account during daily practice. Although IM injection is considered to be an easy and safe method of administering various drugs under many circumstances, it can cause soft tissue damage, thereby leaving the injection site vulnerable to infection. Indeed, local infections following IM injection, including cellulitis, subcutaneous abscesses and necrotizing fasciitis, have been reported (1) (2) (3) (4) . Genus Staphylococcus and Streptococcus are generally the main causative pathogens in such cases (5) (6) (7) (8) (9) .
The genus Streptococcus is classified into α-, β-and γ-hemolytic groups based on the type of hemolysis exhibited. Moreover, the β-hemolytic group of pyogenic streptococci is divided into S. pyogenes [group A streptococcus (GAS)], S. agalactiae [group B streptococcus (GBS)] and Streptococcus dysgalactiae subsp. equisimilis [group G streptococcus (SDSE)] according to the Lancefield classification system.
Of the various types of infections caused by streptococci, streptococcal toxic shock syndrome (STSS) is the most severe systemic illness classically associated with GAS infection. Despite its progressive course, STSS does not manifest with any specific clinical features. Therefore, STSS is frequently misdiagnosed or diagnosed relatively late in the clinical course and subsequently carries a poor prognosis (10) . SDSE has been recently reported to be a causative pathogen of this fatal disease (11, 12) .
We herein describe a fatal case of severe and rapidly progressive SDSE-induced STSS possibly caused by an IM injection, a procedure that is routinely performed in daily practice. of unknown etiology, pulmonary tuberculosis and gastrectomy with Billroth II reconstruction due to gastric ulcers visited his primary care physician complaining of the usual neck pain. He received analgesic treatment and returned home. However, he presented to the other hospital with persistent neck pain the following day. He exhibited no signs of inflammation such as redness, swelling or tenderness in the neck region. After scrubbing the injection site with an alcohol prep pad, the patient received an IM injection of pentazocine into his right deltoid muscle. Shortly afterward, his pain subsided and he returned home.
The patient presented to our emergency room (ER) 23 hours later with a chief complaint of pain in the right deltoid muscle injection site. The patient also complained of systemic pain and numbness. His vital signs on arrival were as follows: blood pressure: 160/86 mmHg; heart rate: 92 beats/min; body temperature: 35.6 ; respiratory rate: 60 breaths/min; and oxygen saturation: 98% on room air. A physical examination conducted at that time revealed hyperventilation, systemic livedo reticularis and epigastric tenderness rather than right deltoid muscle tenderness.
The laboratory test results revealed a high inflammatory state, muscular damage, renal failure, disseminated intravascular coagulopathy (DIC) and respiratory alkalosis (Table 1) . Macroscopic observations of blood cultures and laboratory tests indicated hemolysis.
Based on a systemic contrast-enhanced computed tomography (CT) scan, duodenal perforation was the only suspected cause of the patient's symptoms. However, by then, the patient's condition and consciousness had rapidly deteriorated. Consequently, we could no longer obtain a precise history, assess complaints or conduct a proper physical examination. The systemic livedo reticularis and subcutaneous hemorrhage worsened. Although surgery was attempted, the patient was in an extremely poor general condition and was assigned an American Society of Anesthesiologists score of 5. Meanwhile, he went into respiratory arrest and ultimately died seven hours after arriving at the ER and 30 hours following the IM injection.
Considering the patient's clinical course, including the abdominal symptoms, the rapid progression of circulatory failure and the CT findings, the suspected cause of death was panperitonitis or intestinal ischemic disease. Following a postmortem full-body CT scan that failed to reveal a specific cause of death, an autopsy was performed with the permission of the patient's family members.
The autopsy revealed diffuse subcutaneous hemorrhage, which suggested a profound bleeding tendency. Microscopically, intraglomerular fibrin, thrombosis and acute tubular necrosis were observed, indicating DIC and acute renal impairment, respectively. The presence of tubular casts, along with an elevated creatinine kinase level, was indicative of rhabdomyolysis. An abdominal examination conducted during the autopsy revealed thinning of the intestinal wall at the duodenum; however, no intestinal perforation or panperitonitis was detected. No intestinal ischemic diseases, such as non-occlusive mesenteric ischemia or superior mesenteric artery occlusion were detected. However, pulmonary edema with alveolar hemorrhage, adrenal hemorrhage and residual tuberculous pleural thickening were observed. No significant findings were identified in the neck region, where the patient's pain had been primarily focused.
Before the autopsy was performed, a clinician noticed swelling of the patient's right deltoid muscle and purulent discharge at the IM injection site. However, these findings were considered to be nonspecific and unsubstantial; therefore, no specimens were obtained from the injection site for bacterial culture or pathological investigation. After the autopsy was completed, SDSE was detected in two sets of blood cultures (Pos Combo Panel 3.1J, Microscan Walkaway 40SI, Siemens), and the emm type of the strain was later identified as stG485 at the Kitasato Institute for Life Sciences (13).
Discussion
SDSE, which was first reported in 1996, is now serologically divided into two groups: group C and group G. Common SDSE colonization sites include the human nasopharynx, genital tract, intestines and skin. This organism has been recently identified as the main pathogen involved in severe soft tissue infections that resemble those caused by other β-hemolytic streptococci (14) . However, previous studies have demonstrated that, in contrast to GAS, Group G Streptococcus (GGS) infections generally occur among elderly patients with underlying malignancies or diabetes mellitus (15) (16) (17) . Indeed, patients suffering from GGS infection are encountered more frequently among the aging population in Japan, where an increased number of patients have underlying medical conditions (18) .
In this report, we present the GGS bacteremia cases reported at our institute during the past seven years ( Table 2 ). The average patient age was 79 years (range: 62-96 years) and soft tissue infections accounted for 72.7% of the cases, which is almost the same rate as that observed in a previous report (16) . The reported mortality rates of GGS infection range from 5% to 30% (16, 19, 20) ; however, the 28-day mortality rate at our facility is 63.6%. The disease prevalence rates of malignancy and diabetes mellitus have been calculated to be 36.4% and 18.2%, respectively; however, all patients had certain underlying medical conditions. These observations confirm that systemic GGS infections, especially soft tissue infections, commonly occur among aging patients with underlying diseases and lead to high mortality rates, as has been previously reported (21). Of the seven patients who did not undergo surgical intervention, six (85.7%) died within 28 days; among three patients who underwent surgical debridement, two (66.7%) survived. Hence, we believe that GGS bacteremia, which is generally caused by soft tissue, bone or joint infections, should be treated with appropriate surgical intervention as well as antimicrobial therapy.
Previous studies have reported that SDSE is closely and quantitatively related to GAS. Furthermore, many genes encoding virulence factors in GAS have been identified in SDSE, but not in other streptococci, including streptolysin O, NADase and streptokinase A (22) . This observation suggests that these factors are important for the development of invasive disease. Conversely, GGS lacks several genes present in GAS that encode for other superantigens such as cysteine protease speB.
M protein, which is encoded by emm genes, is a wellknown major GAS virulence factor with a filamentous structure extending from the bacterial cell wall surface that func- tions as an adhesion molecule for host cells, inhibits the activation of the alternative complement pathway and impedes phagocytosis by polymorphonuclear leukocytes (23) . In epidemiological studies of STSS caused by GAS, M1 and M3 have been the most commonly isolated strains (22, (24) (25) (26) . However, other M types of GAS have also been isolated, although infrequently, from STSS patients. Consequently, no M proteins of GAS specific for STSS have been identified thus far. Although it is considered to be unique to GAS, some studies have shown that the M protein appears at the surface of other streptococci as well (27) . Moreover, although GAS is the representative causative pathogen of STSS, other Lancefield streptococci groups, including SDSE, have been recently reported to cause STSS (11, 12, 28, 29) .
In the present case, the pathogen was identified as stG 485.0, which is the third most commonly detected strain known to cause severe infections in Japan (21). Sunaoshi et al. (30) reported a significantly different distribution of emm types between invasive and noninvasive GGS infections, such that stG485, stG6792 and stG2078 were predominately detected among isolates from invasive infections, while stG 10, stG6 and stC36 were primarily observed in relatively noninvasive cases.
We examined recent literature reviews for observations on the relationship between the M protein of SDSE and STSS [ (Table 3) (10, 11, 29-35) ]. The stG485, stG2078 and stG6792 strains were commonly detected; however, we were unable to confirm an association between specific M proteins or emm genes of SDSE and SDSE-caused STSS. The relationship between specific M proteins of GAS or GGS and the occurrence of STSS remains unclear.
The poor outcomes of patients with STSS are primarily due to the disease's nonspecific features at presentation, and recognizing this fact can help to make a diagnosis of STSS at an early stage. Delayed diagnosis leads to delays in the appropriate administration of antimicrobials and the proper surgical debridement. Previous studies have suggested that a high index of suspicion may allow for the only chance of survival (11, (36) (37) (38) . The patient in the present case was clinically diagnosed with intestinal perforation; however, that diagnosis was pathologically refuted by the autopsy results. The patient was diagnosed with probable STSS caused by SDSE based on the presence of hypotension, multiorgan involvement including renal impairment, coagulopathy, liver involvement, acute respiratory distress syndrome and isolation of the SDSE pathogen. The significant elevation in the creatinine kinase level, given the presence of renal tubular casts, was explained by rhabdomyolysis caused by STSS or by a local soft tissue infection such as pyomyositis or necrotizing fasciitis at the IM injection site. However, since no pathological specimens were obtained from the injection site, none of the possible explanations can be excluded or confirmed. Although the incidence of SDSE-induced STSS is reported to be lower than that of STSS caused by GAS (7%) (39) , worse overall prognoses for SDSE infection are expected, since SDSE particularly tends to occur in elderly patients with underlying diseases.
IM injection, per se, is an essential and fundamental skill of health care workers that is routinely performed on a daily basis. However, the possible hazardous effects of IM injections are generally not seriously considered. Hematomas, nerve damage, quadriceps contracture (especially among children) and local infection are relatively common complications of this procedure. IM injections can provoke soft tissue trauma and even necrosis at the infection site and can provide a site of entry for infection, even when correctly administered (1) (2) (3) (4) . Previous studies have not examined the possible risk factors for skin and soft tissue infection after IM injection. However, to the best of our knowledge, no previous reports have evaluated STSS following IM injection. Considering that GGS is among the representative microorganisms of human skin flora, it is conceivable that a skin breach may constitute a port of entry for infecting organisms, thus sometimes leading to serious condition (14) .
The relationship between IM injection of non-steroidal anti-inflammatory drugs (NSAIDs) and severe infection was described by Frick et al. (5) . They stated that NSAIDs disrupt normal infectious disease progression by suppressing fever and pain through prostaglandin synthesis inhibition, thus blurring the signs that indicate the onset of serious infection (40) . Accordingly, NSAIDs themselves can be a risk factor for serious infectious complications of IM injection. In the present case, however, pentazocine, not NSAIDs, was administered through IM injection. We assume that its analgesic effects, which are similar to those of NSAIDs, may play a role in the progression of infection since it also masks the symptoms of inflammation. However, we could not find any previous studies that suggested the presence of an association between pentazocine and severe infection.
The autopsy did not reveal the exact cause of death; however, the patient had received an IM injection in the right deltoid muscle before his death, and the injection site was found to be swollen. In addition, SDSE, which often causes serious soft tissue infections, was detected in the patient's blood culture. Based on these clinical presentations and the exclusion of other sources of infection by the autopsy, we concluded that STSS caused by SDSE regrettably occurred as a result of the IM injection procedure itself or due to a skin breach resulting from the IM injection. In addition to STSS, adrenal insufficiency caused by adrenal hemorrhage, which was observed during the autopsy, was probably caused by DIC and it constituted another reason for the patient's aggressive course.
In summary, an 88-year-old man died of a rapidly progressive systemic SDSE infection that was later diagnosed as STSS possibly caused by an IM injection. The causative pathogen was identified as stG485. According to literature reviews, no relationships have been established thus far between specific M proteins, or emm types, and the pathogenesis of STSS. IM injection is a common technique that is frequently performed worldwide; however, it can sometimes provoke local or even systemic infection, as observed in the present case. This fact should therefore be seriously considered by all health care workers, and every aspect of the injection procedure should be carefully performed, especially when immunologically compromised patients are involved.
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